Second-line treatment for primary central nervous system lymphoma

por Reni, M, Ferreri, A J M, Villa, E
Publicado 1999

How we treat primary central nervous system lymphoma

por Calimeri, T., Steffanoni, S., Gagliardi, F., Chiara, A., Ferreri, A.J.M.
Publicado 2021

Methotrexate area under the curve is an important outcome predictor in patients with primary CNS lymphoma: A pharmacokinetic–pharmacodynamic analysis from the IELSG no. 20 trial

por Joerger, M, Huitema, A D R, Krähenbühl, S, Schellens, J H M, Cerny, T, Reni, M, Zucca, E, Cavalli, F, Ferreri, A J M
Publicado 2010

Exposure to animals and increased risk of marginal zone B-cell lymphomas of the ocular adnexae

por Dolcetti, R, Serraino, D, Dognini, G, Govi, S, Crocchiolo, R, Ghia, P, Pasini, E, Ponzoni, M, Talamini, R, De Paoli, P, Doglioni, C, Ferreri, A J M
Publicado 2012

Area under the curve of methotrexate and creatinine clearance are outcome-determining factors in primary CNS lymphomas

por Ferreri, A J M, Guerra, E, Regazzi, M, Pasini, F, Ambrosetti, A, Pivnik, A, Gubkin, A, Calderoni, A, Spina, M, Brandes, A, Ferrarese, F, Rognone, A, Govi, S, Dell'Oro, S, Locatelli, M, Villa, E, Reni, M
Publicado 2004

Temozolomide as salvage treatment in primary brain lymphomas

por Reni, M, Zaja, F, Mason, W, Perry, J, Mazza, E, Spina, M, Bordonaro, R, Ilariucci, F, Faedi, M, Corazzelli, G, Manno, P, Franceschi, E, Pace, A, Candela, M, Abbadessa, A, Stelitano, C, Latte, G, Ferreri, A J M
Publicado 2007

P1208: CHARACTERISTICS AND CLINICAL OUTCOMES OF PATIENTS WITH ALK-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA: REPORT FROM THE PROSPECTIVE INTERNATIONAL T-CELL LYMPHOMA PROJECT

por Chiattone, C., Civallero, M., Fischer, T., Miranda, E., Manni, M., Zing, N. P. C., Pileri, S. A., Montoto, S., Horwitz, S. M., Cabrera, M. E., De Souza, C. A., Nagler, A., Luminari, S., Ferreri, A. J. M., Carson, K. R., Re, A., Rigacci, L., Nassi, L., Federico, M., Inghirami, G.
Publicado 2022

P1239: TISLELIZUMAB, A PD-1 INHIBITOR FOR RELAPSED/REFRACTORY MATURE T- AND NK-CELL NEOPLASMS: RESULTS FROM A PHASE 2 STUDY

por Bachy, E., Savage, K. J., Huang, H., Kwong, Y. L., Gritti, G., Zhang, Q., Liberati, A. M., Cao, J., Yang, H., Hao, S., Hu, J., Zhou, K., Russo, F., Zhang, H., Sang, W., Ji, J., Ferreri, A. J. M., Damaj, G. L., Liu, H., Zhang, W., Ke, X., Ghiggi, C., Huang, S., Li, X., Yao, H., Paik, J., Novotny, W., Zhou, W., Zhu, H., Huang, J., Zinzani, P. L.
Publicado 2022